Researchers have established consensus molecular subtypes for esophageal squamous cell carcinoma, which may guide metastasis prediction, immunotherapy, and precision medicine. Studies have explored the biological and prognostic relevance of various molecular mechanisms in this type of cancer, as well as in other related cancers. The findings may have implications for prognosis, treatment strategy, and vaccine development, although the specific details and applications of these discoveries are still being investigated.